AETHLON MEDICAL INC (AEMD) Forecast, Price Target & Analyst Ratings
NASDAQ:AEMD • US00808Y6041
1.7 USD
-0.04 (-2.3%)
At close: Mar 6, 2026
1.79 USD
+0.09 (+5.29%)
After Hours: 3/6/2026, 8:00:00 PM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for AETHLON MEDICAL INC (AEMD).
Forecast Snapshot
Consensus Price Target
$11.73
+ 590.00% Upside
Next Earnings Forecast
Release DateJun 24, 2026
PeriodQ4 / 2026
EPS Estimate-$2.21
Revenue Estimate
ChartMill Buy Consensus
45.71%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
$11.73
Upside
+ 590.00%
From current price of $1.70 to mean target of $11.73, Based on 7 analyst forecasts
Low
$8.08
Median
$11.73
High
$15.75
Price Target Revisions
1 Month
-7.07%
3 Months
-7.07%
Price Target Summary
7 analysts have analysed AEMD and the average price target is 11.73 USD. This implies a price increase of 590% is expected in the next year compared to the current price of 1.7.
The average price target has been revised downward by 7.07% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
45.71%
AEMD was analyzed by 7 analysts. The buy percentage consensus is at 46. So analysts seem to be rather neutral about AEMD.
In the previous month the buy percentage consensus was at a similar level.
AEMD was analyzed by 7 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2025-08-14 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2025-03-10 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-02-19 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-30 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-06-24 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-03-04 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-10-24 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2022-11-15 | Maxim Group | Downgrade | Buy -> Hold |
| 2021-06-25 | HC Wainwright & Co. | Maintains | Buy |
| 2021-06-01 | HC Wainwright & Co. | Initiate | Buy |
Next Earnings Forecast Details
Next Earnings Details
Release DateJun 24, 2026
PeriodQ4 / 2026
EPS Estimate-$2.21
Revenue Estimate
Revenue Q2QN/A
EPS Q2Q97.23%
Number of Analysts5
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
-12.85%
EPS (3 Months)
-12.85%
Next Earnings Summary
AEMD is expected to report earnings on 6/24/2026. The consensus EPS estimate for the next earnings is -2.21 USD and the consensus revenue estimate is 0 USD.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 660K 1.54% | 290K -56.06% | 570K 96.55% | -100.00% | 9.051M | 24.515M 170.85% | 35.747M 45.82% | 48.405M 35.41% | ||||||
| EBITDA YoY % growth | -7.85M -33.05% | -10.3M -31.21% | -11.66M -13.20% | N/A -5.30% | N/A 26.69% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -7.89M -33.05% | -10.42M -32.07% | -11.9M -14.20% | -13.661M -6.19% | -9.489M 26.09% | -7.713M 17.42% | -9.621M -24.75% | -13.306M -38.30% | -21.177M -59.16% | -14.178M 33.05% | -316.2K 97.77% | 8.689M 2,847.94% | 16.377M 88.48% | |
| Operating Margin | -1,195.45% | -3,593.10% | -2,087.72% | N/A | N/A | N/A | N/A | N/A | N/A | -156.65% | -1.29% | 24.31% | 33.83% | |
| EPS YoY % growth | N/A 77.50% | -568.00 0.08% | -472.00 16.90% | -443.36 16.95% | -58.96 65.99% | -11.38 91.47% | -3.99 64.90% | -5.00 -25.16% | -5.00 | -3.37 32.65% | -0.10 96.97% | 1.94 2,000.00% | 3.67 89.47% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -2.21 97.23% | -0.77 90.94% | -1.43 61.82% | -1.43 41.71% | -1.43 35.38% |
| Revenue Q2Q % growth | |||||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -2.241M -11.81% | -3.269M -82.39% | -4.705M -218.68% | -4.752M -134.24% | -4.8M -114.23% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
25.20%
EPS Next 5 Year
14.58%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
AETHLON MEDICAL INC / AEMD Forecast FAQ
What do analysts expect the price target to be for AETHLON MEDICAL INC (AEMD)?
7 analysts have analysed AEMD and the average price target is 11.73 USD. This implies a price increase of 590% is expected in the next year compared to the current price of 1.7.
Can you provide the upcoming earnings date for AETHLON MEDICAL INC?
AETHLON MEDICAL INC (AEMD) will report earnings on 2026-06-24, after the market close.
Can you provide the consensus estimates for AETHLON MEDICAL INC next earnings?
The consensus EPS estimate for the next earnings of AETHLON MEDICAL INC (AEMD) is -2.21 USD and the consensus revenue estimate is 0 USD.
How many analysts have analysed AETHLON MEDICAL INC (AEMD)?
The number of analysts covering AETHLON MEDICAL INC (AEMD) is 7.